Cite
Durable clinical response to immunotherapy in EGFR-mutated lung adenocarcinoma with squamous cell carcinoma transformation and high expression of PD-L1 after resistance development: A case report
MLA
Zhongsheng Peng, and Yanjun Xu. “Durable Clinical Response to Immunotherapy in EGFR-Mutated Lung Adenocarcinoma with Squamous Cell Carcinoma Transformation and High Expression of PD-L1 after Resistance Development: A Case Report.” Current Problems in Cancer: Case Reports, vol. 8, no. 100199-, Dec. 2022. EBSCOhost, https://doi.org/10.1016/j.cpccr.2022.100199.
APA
Zhongsheng Peng, & Yanjun Xu. (2022). Durable clinical response to immunotherapy in EGFR-mutated lung adenocarcinoma with squamous cell carcinoma transformation and high expression of PD-L1 after resistance development: A case report. Current Problems in Cancer: Case Reports, 8(100199-). https://doi.org/10.1016/j.cpccr.2022.100199
Chicago
Zhongsheng Peng, and Yanjun Xu. 2022. “Durable Clinical Response to Immunotherapy in EGFR-Mutated Lung Adenocarcinoma with Squamous Cell Carcinoma Transformation and High Expression of PD-L1 after Resistance Development: A Case Report.” Current Problems in Cancer: Case Reports 8 (100199-). doi:10.1016/j.cpccr.2022.100199.